STRUKTUR PROTEOMIK VIRUS DENGUE DAN MANFAATNYA SEBAGAI TARGET ANTIVIRUS
<p>Abstrak<br />Virus dengue (DENV) telah menyebabkan sekitar 50 juta kasus infeksi demam berdarah setiap tahunnya, akan tetapi hingga saat ini belum terdapat vaksin maupun antivirus yang mampu mencegah atau mengobati penyakit tersebut. Selama pengembangan vaksin dan antivirus, diperoleh...
Main Author: | Novia Rachmayanti |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Andalas
2014-09-01
|
Series: | Majalah Kedokteran Andalas |
Subjects: | |
Online Access: | http://jurnalmka.fk.unand.ac.id/index.php/art/article/view/152 |
Similar Items
-
Frontiers in dengue virus research /
by: Hanley, Kathryn A., editor, et al.
Published: (c201) -
Dengue virus /
by: Rothman, Alan L., editor
Published: (c201) -
Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2
by: Carolina de la Guardia, et al.
Published: (2018-03-01) -
Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation
by: Leo Uchida, et al.
Published: (2016-02-01) -
Molecular epidemiology of dengue viruses in Brazil Epidemiologia molecular dos vírus dengue no Brasil
by: Rita Maria Ribeiro Nogueira, et al.
Published: (2000-01-01)